American Century Companies Inc. lowered its stake in shares of Healthequity Inc (NASDAQ:HQY) by 21.5% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 75,326 shares of the company’s stock after selling 20,670 shares during the period. American Century Companies Inc. owned approximately 0.12% of Healthequity worth $5,657,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Segall Bryant & Hamill LLC bought a new stake in Healthequity during the second quarter worth about $1,126,000. Schwab Charles Investment Management Inc. grew its stake in Healthequity by 10.6% during the second quarter. Schwab Charles Investment Management Inc. now owns 276,878 shares of the company’s stock worth $20,794,000 after buying an additional 26,635 shares during the last quarter. Russell Investments Group Ltd. grew its stake in Healthequity by 203.2% during the second quarter. Russell Investments Group Ltd. now owns 14,740 shares of the company’s stock worth $1,109,000 after buying an additional 9,879 shares during the last quarter. Pier Capital LLC grew its stake in Healthequity by 89.9% during the second quarter. Pier Capital LLC now owns 99,609 shares of the company’s stock worth $7,481,000 after buying an additional 47,169 shares during the last quarter. Finally, SG Americas Securities LLC grew its stake in Healthequity by 18.5% during the second quarter. SG Americas Securities LLC now owns 26,846 shares of the company’s stock worth $2,016,000 after buying an additional 4,194 shares during the last quarter. 96.99% of the stock is owned by institutional investors and hedge funds.
HQY opened at $96.92 on Thursday. Healthequity Inc has a one year low of $42.92 and a one year high of $97.93. The company has a market cap of $5.85 billion, a PE ratio of 179.48, a P/E/G ratio of 3.92 and a beta of 1.46.
Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 4th. The company reported $0.34 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.12. Healthequity had a net margin of 22.91% and a return on equity of 13.47%. The business had revenue of $71.10 million for the quarter, compared to analysts’ expectations of $69.84 million. During the same period in the prior year, the firm earned $0.27 earnings per share. Healthequity’s revenue was up 25.0% compared to the same quarter last year. analysts anticipate that Healthequity Inc will post 0.72 EPS for the current fiscal year.
Several brokerages have weighed in on HQY. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price objective on shares of Healthequity in a research note on Wednesday. They noted that the move was a valuation call. SunTrust Banks increased their price target on shares of Healthequity to $105.00 and gave the company a “buy” rating in a research note on Wednesday. Oppenheimer increased their price target on shares of Healthequity from $85.00 to $104.00 and gave the company an “outperform” rating in a research note on Wednesday. Cantor Fitzgerald increased their price target on shares of Healthequity from $68.00 to $80.00 and gave the company a “neutral” rating in a research note on Wednesday. Finally, Wells Fargo & Co reissued an “outperform” rating and set a $105.00 price target (up from $84.00) on shares of Healthequity in a research note on Wednesday. Three research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $90.25.
In related news, VP Angelique Christine Hill sold 8,000 shares of the stock in a transaction that occurred on Friday, June 8th. The shares were sold at an average price of $77.45, for a total value of $619,600.00. Following the transaction, the vice president now directly owns 18,471 shares in the company, valued at $1,430,578.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Frank Medici sold 15,596 shares of the stock in a transaction that occurred on Tuesday, July 10th. The shares were sold at an average price of $80.15, for a total transaction of $1,250,019.40. Following the completion of the transaction, the director now owns 26,341 shares in the company, valued at $2,111,231.15. The disclosure for this sale can be found here. Insiders have sold 49,500 shares of company stock worth $3,932,081 over the last three months. 4.00% of the stock is owned by insiders.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: Penny Stocks, What You Need To Know
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.